Treatment of lung cancer in the elderly: Influence of comorbidity on toxicity and survival

Reports of Practical Oncology and Radiotherapy

Volumn 16, Issue 2, 2011, Pages 45-48

  Cardia, Joana ^a   Calçada, Cármen ^a   Pereira, Helena ^a  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

Author keywords

Comorbidity; Elderly; Lung cancer; Radiotherapy; Toxicity

Indexed keywords

CISPLATIN; ETOPOSIDE; GEMCITABINE; PACLITAXEL;

AGED; ARTICLE; BLOOD TOXICITY; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMORBIDITY; ESOPHAGUS DISEASE; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; LEUKOPENIA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL RATE; THERAPY EFFECT; TREATMENT OUTCOME;

EID: 79951904924     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rpor.2011.01.001     Document Type: Article

References (8)

1. Gridelli C., Langer C., Maione P., Rossi P., Schild S. Lung cancer in the elderly. J Clin Oncol 2007, 25:1898-1907.
2. Weinmann M., Branislav J., Toomes H., Friedel G., Bamerg M. Treatment of lung cancer in the elderly. Part I: non-small cell lung cancer. Lung Cancer 2003, 39:233-253.
3. Pignon T., Gregor A., Koning C.S., Roussel A., Glabbeke M.V., Scalliet P. Age has no impact on acute and late toxicity of curative thoracic radiotherapy. Radiother Oncol 1998, 46(3):239-248.
4. Casas F., Kepka L., Agarwal J.P., Dawotola D., Gaye P., et al. Radiochemotherapy in the elderly with lung cancer. Expert Rev Anticancer Ther 2009, 9(October (10)):1405-1411.
5. Bayman N., Alam N., Faivre-Finn C. Radiotherapy for lung cancer in the elderly. Lung Cancer 2010, [January 14, Epub ahead of print].
6. Schild S., Madrekar S., Jatoi A., McGinnis W., Stella P., Deming R., et al. The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer. Cancer 2007, 15(110(2)):363.
7. Lonardi F., Coeli M., Pavanato G., Adami F., Gioga G., Campostrini F. Radiotherapy for non-small cell lung cancer in patients aged 75 and over: safety, effectiveness and possible impact on survival. Lung Cancer 2000, 28(April (1)):43-50.
8. Schild S.E., Stella P.J., Geyer S.M., et al. The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol 2003, 21:3201-3206.